Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer Patients

Meltzer, Lauren R.; Meade, Cathy D.; Diaz, Diana B.; Carrington, Monica S.; Brandon, Thomas H.; Jacobsen, Paul B.; McCaffrey, Judith C.; Haura, Eric B.; Simmons, Vani N.

doi:10.1007/s13187-016-1089-z

Cited by 7 publications

(9 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The development of the intervention materials is described elsewhere 18,22 . The original Forever Free intervention includes 8 booklets: a general overview followed by specific topics (“Smoking Urges”; “Smoking and Weight”; “What if You Have a Cigarette?”; “Your Health”; “Smoking, Stress, and Mood”; “Lifestyle Balance”; and “Life Without Cigarettes”).…”

Section: Methodsmentioning

confidence: 99%

Preventing smoking relapse in patients with cancer: A randomized controlled trial

Simmons

Sutton

Meltzer

et al. 2020

Cancer

Self Cite

View full text Add to dashboard Cite

Background Abstaining from smoking after a cancer diagnosis is critical to mitigating the risk of multiple adverse health outcomes. Although many patients with cancer attempt to quit smoking, the majority relapse. The current randomized controlled trial evaluated the efficacy of adapting an evidence‐based smoking relapse prevention (SRP) intervention for patients with cancer. Methods The trial enrolled 412 patients newly diagnosed with cancer who had recently quit smoking. Participants were randomized to usual care (UC) or SRP. Participants in the UC group received the institution's standard of care for treating tobacco use. Participants in the SRP group in addition received a targeted educational DVD plus a validated self‐help intervention for preventing smoking relapse. The primary outcome was smoking abstinence at 2 months, 6 months, and 12 months. Results Abstinence rates for participants in the SRP and UC groups were 75% versus 71% at 2 months and 69% versus 64% at 6 months (Ps > .20). At 12 months, abstinence rates among survivors were 68% for those in the SRP group and 63% for those in the UC group (P = .38). Post hoc analyses revealed that across 2 months and 6 months, patients who were married/partnered were more likely to be abstinent after SRP than UC (P = .03). Conclusions A smoking relapse prevention intervention did not reduce relapse rates overall, but did appear to have benefited those participants who had the social support of a partner. Future work is needed to extend this effect to the larger population of patients.

show abstract

Section: Methodsmentioning

confidence: 99%

Preventing smoking relapse in patients with cancer: A randomized controlled trial

Simmons

Sutton

Meltzer

et al. 2020

Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…All participants received standard of care. Those randomized to the intervention condition also received an educational DVD with smoking relapse‐prevention information designed for cancer patients and eight relapse‐prevention booklets that were mailed over 3 months. Assessments were completed at baseline and at 2, 6, and 12 months post‐baseline.…”

Section: Methodsmentioning

confidence: 99%

Does smoking abstinence predict cancer patients' quality of life over time?

et al. 2019

Self Cite

View full text Add to dashboard Cite

Objective Smoking cessation improves quality of life (QOL) in the general population. However, there is limited information on the role of smoking status on QOL among cancer patients. Moreover, previous studies tended to analyze smoking status dichotomously and at a single point in time, potentially reducing the strength of the relation between smoking cessation and QOL. This study examined the association of smoking abstinence and QOL over time, including depression, pain, and fatigue in patients with a wide variety of cancers. Methods Participants were 332 cancer patients (eg, gynecologic, breast, thoracic, head and neck, and genitourinary) who had been abstinent for at least 24 hours. Days abstinent and QOL were assessed at baseline and 2, 6, and 12 months later. Latent growth curve models examined if days abstinent was associated with QOL at each assessment. Baseline demographics (eg, sex and income) and smoking history variables (eg, nicotine dependence) were used as time‐invariant covariates. Results The final model for each QOL component had good‐to‐excellent fit. More days abstinent was associated with lower depression at all follow‐ups and with lower fatigue at 12 months but was not associated with pain. Conclusions QOL was better among patients who quit smoking for longer periods. Findings suggest different timelines, with smoking abstinence most immediately associated with lower depression, followed by lower fatigue. Although pain decreased over time, it was not associated with length of smoking abstinence. Results reinforce the relationship between sustained smoking cessation and QOL, which should be communicated to patients.

show abstract

“…Additional details describing the DVD development process are described elsewhere. 29 Participants view the Surviving SmokeFree ® DVD at the time of enrollment and are provided a copy to take home.…”

Section: Methodsmentioning

confidence: 99%

Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial

Diaz

Brandon

Sutton

et al. 2016

Contemporary Clinical Trials

Self Cite

View full text Add to dashboard Cite

Continued smoking after a cancer diagnosis contributes to several negative health outcomes. Although many cancer patients attempt to quit smoking, high smoking relapse rates have been observed. This highlights the need for a targeted, evidence-based smoking-relapse prevention intervention. The design, method, and baseline characteristics of a randomized controlled trial assessing the efficacy of a self-help smoking-relapse prevention intervention are presented. Cancer patients who had recently quit smoking were randomized to one of two conditions. The Usual Care (UC) group received the institution’s standard of care. The smoking relapse-prevention intervention (SRP) group received standard of care, plus 8 relapse-prevention booklets mailed over a 3 month period, and a targeted educational DVD developed specifically for cancer patients. Four hundred and fourteen participants were enrolled and completed a baseline survey. Primary outcomes will be self-reported smoking status at 6 and 12-months after baseline. Biochemical verification of smoking status was completed for a subsample. If found to be efficacious, this low-cost intervention could be easily disseminated with significant potential for reducing the risk of negative cancer outcomes associated with continued smoking.

show abstract

Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer Patients

Cited by 7 publications

References 24 publications

Preventing smoking relapse in patients with cancer: A randomized controlled trial

Preventing smoking relapse in patients with cancer: A randomized controlled trial

Does smoking abstinence predict cancer patients' quality of life over time?

Smoking relapse-prevention intervention for cancer patients: Study design and baseline data from the surviving SmokeFree randomized controlled trial

Contact Info

Product

Resources

About